Among early stage breast cancer patients, elevated levels of fasting insulin are associated with distant recurrence and mortality [29] and while elevated HOMA-IR scores are associated with reductions in breast cancer survival and all-cause survival [14]. The gene discussed is INS; the disease is breast carcinoma.